In vitro percutaneous absorption evaluation of phenobarbital through hairless mouse, adult and premature human skin

[1]  S. Almog,et al.  Transdermal delivery of tetrahydrocannabinol , 1988 .

[2]  M. Groves,et al.  Diffusion of [2-14C]diazepam across isolated hairless mouse stratum corneum/epidermal tissues. , 1988, The Journal of investigative dermatology.

[3]  J. Hadgraft,et al.  Skin permeability in the newborn. , 1987, The Journal of investigative dermatology.

[4]  R. Bronaugh,et al.  Methods for in vitro percutaneous absorption studies III: hydrophobic compounds. , 1984, Journal of pharmaceutical sciences.

[5]  V. Harpin,et al.  Barrier properties of the newborn infant's skin. , 1983, The Journal of pediatrics.

[6]  Ronald C. Wester,et al.  Relevance of animal models for percutaneous absorption , 1980 .

[7]  L. Lockman,et al.  Phenobarbital dosage for control of neonatal seizures , 1979, Neurology.

[8]  R. A. Jones,et al.  Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies. , 1979, Archives of disease in childhood.

[9]  T. Franz.  Percutaneous absorption on the relevance of in vitro data. , 1975, The Journal of investigative dermatology.

[10]  R. Scheuplein,et al.  Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. , 1973, The Journal of investigative dermatology.

[11]  N. Esterly,et al.  Increased skin permeability in preterm infants. , 1971 .

[12]  E. Christophers,et al.  PREPARATION OF ISOLATED SHEETS OF HUMAN STRATUM CORNEUM. , 1963, Archives of dermatology.

[13]  N. Evans,et al.  Development of the epidermis in the newborn. , 1986, Biology of the neonate.

[14]  R. Bronaugh,et al.  Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. , 1985, Journal of pharmaceutical sciences.